(USPX) Franklin Templeton Trust - Ratings and Ratios
Large-Cap Stocks, Mid-Cap Stocks, US Equities, Market-Cap Weighted
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.7% |
| Value at Risk 5%th | 32.1% |
| Relative Tail Risk | 4.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | 0.25 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.440 |
| Beta | 0.982 |
| Beta Downside | 0.980 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.21% |
| Mean DD | 2.26% |
| Median DD | 1.12% |
Description: USPX Franklin Templeton Trust November 13, 2025
The Franklin LibertyQ Global Equity ETF (NYSE ARCA: USPX) seeks to track a Morningstar-calculated, free-float-adjusted market-cap weighted index, allocating at least 80 % of its assets to the index’s component securities. The index covers large- and mid-cap U.S. stocks that together represent roughly the top 85 % of the investable U.S. equity market by float-adjusted market cap, and the fund is classified as a non-diversified large-blend ETF.
As of the latest filing, USPX carries an expense ratio of 0.20 % and manages approximately $1.2 billion in assets, with an average portfolio turnover of about 30 % annually. The top holdings are heavily weighted toward information technology (≈ 23 %) and health care (≈ 15 %), sectors that have benefited from robust earnings growth and ongoing digital transformation. Recent macro-economic drivers-such as the Federal Reserve’s stance on interest rates and corporate earnings resilience-have kept the ETF’s beta to the S&P 500 around 1.05, indicating slightly higher volatility than the broad market.
If you want a deeper, data-driven look at USPX’s risk-adjusted performance and sector dynamics, ValueRay’s analytical platform provides the tools you need to explore further.
USPX ETF Overview
| Market Cap in USD | 1,610m |
| Category | Large Blend |
| TER | 0.03% |
| IPO / Inception | 2016-06-01 |
| Return 12m vs S&P 500 | 0.02% |
| Analyst Rating | - |
USPX Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 1.11% |
| Yield on Cost 5y | 2.01% |
| Yield CAGR 5y | -8.47% |
| Payout Consistency | 92.5% |
| Payout Ratio | - |
USPX Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 19.67% |
| CAGR/Max DD Calmar Ratio | 1.02 |
| CAGR/Mean DD Pain Ratio | 8.71 |
| Current Volume | 57.9k |
| Average Volume | 27.4k |
What is the price of USPX shares?
Over the past week, the price has changed by -2.93%, over one month by -2.95%, over three months by +2.53% and over the past year by +11.87%.
Is USPX a buy, sell or hold?
What are the forecasts/targets for the USPX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 65.9 | 14.9% |
USPX Fundamental Data Overview November 20, 2025
Beta = 1.01
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.61b USD (1.61b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.61b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.61b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.64% (E(1.61b)/V(1.61b) * Re(9.64%) + (debt-free company))
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for USPX ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle